Q2 2024 Holdings
Filed 2024-08-14 | 60 holdings | $1.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $160.1M | 1,500,000 | 11.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $112.4M | 2,075,000 | 8.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $102.3M | 750,000 | 7.6% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $74.0M | 1,800,000 | 5.5% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $61.6M | 900,000 | 4.6% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $50.3M | 750,000 | 3.7% |
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $49.9M | 350,000 | 3.7% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $49.0M | 1,200,000 | 3.7% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $39.1M | 925,000 | 2.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $37.3M | 675,000 | 2.8% |
| Immatics NV(IMTX) | SHS | N44445109 | $32.0M | 2,750,000 | 2.4% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $30.4M | 725,000 | 2.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $29.6M | 3,250,000 | 2.2% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $27.1M | 2,300,000 | 2.0% |
| Savara Inc(SVRA) | COM | 805111101 | $26.2M | 6,490,000 | 2.0% |
| iTeos Therapeutics Inc(5E7) | COM | 46565G104 | $26.0M | 1,750,000 | 1.9% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $25.4M | 5,430,000 | 1.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $24.2M | 300,000 | 1.8% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $22.0M | 560,000 | 1.6% |
| Liquidia Corp(LQDA) | COM NEW | 53635D202 | $22.0M | 1,830,000 | 1.6% |
| ALX Oncology Holdings Inc(ALXO) | COM | 00166B105 | $21.7M | 3,600,000 | 1.6% |
| uniQure NV(QURE) | SHS | N90064101 | $21.3M | 4,750,000 | 1.6% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $20.8M | 500,000 | 1.5% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $20.5M | 525,000 | 1.5% |
| Praxis Precision Medicines Inc(PRAX) | COM NEW | 74006W207 | $18.2M | 440,000 | 1.4% |
| Day One Biopharmaceuticals Inc(DAWN) | COM | 23954D109 | $17.2M | 1,250,000 | 1.3% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $16.9M | 350,000 | 1.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $15.5M | 600,000 | 1.2% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $15.1M | 2,665,000 | 1.1% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $13.5M | 840,000 | 1.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $12.9M | 335,000 | 1.0% |
| Immunome Inc(IMNM) | COM | 45257U108 | $12.1M | 1,000,000 | 0.9% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $11.6M | 500,000 | 0.9% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $10.4M | 500,000 | 0.8% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $9.8M | 2,100,000 | 0.7% |
| BioNTech SE(BNTX) | SPONSORED ADS | 09075V102 | $8.0M | 100,000 | 0.6% |
| Inspire Medical Systems Inc(INSP) | COM | 457730109 | $8.0M | 60,000 | 0.6% |
| Pacira BioSciences Inc(PCRX) | COM | 695127100 | $8.0M | 280,000 | 0.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $7.9M | 225,000 | 0.6% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $7.2M | 1,160,000 | 0.5% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $6.6M | 620,000 | 0.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $6.6M | 2,000,000 | 0.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $5.1M | 2,200,000 | 0.4% |
| Passage Bio Inc | COM | 702712100 | $4.8M | 6,052,000 | 0.4% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $4.7M | 600,000 | 0.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.5M | 180,000 | 0.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $3.7M | 440,000 | 0.3% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $3.6M | 1,200,000 | 0.3% |
| MacroGenics Inc(MGNX) | COM | 556099109 | $3.4M | 800,000 | 0.3% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $3.3M | 890,000 | 0.2% |